N2024

Nyhetsarkiv

• Life Sciences N.V. Atai Sells 2,660, 000 Shares of COMPASS Pathways plc (NASDAQ:CMPS) Stock (MarketBeat 28. september)

• The clinic for psychedelic difficulties: where people go when the trip never really ends (The Guardian, 6. september)

• Thomas Hartle Leaves a Legacy of Hope (Lucid News, 6. september)

• Prozac in waterways is changing how fish behaves, research finds (The Guardian. 27. august)

• How Psychedelic Research Got High on Its Own Supply (The New York times, 23. august)

•Lykos, MAPS Cut Staff As New Leadership Takes Charge of MDMA Assisted Therapy Research (Lucid News, 16. august)

• Matthew Perry's assistant among 5 people, including two doctors, charged in "Friends" star's death (AP News, 16. august)

• He Took a Psychedelic to Cure His Addiction. It Was His Last Trip (Rolling Stone, 14. august)

• FDA Denies the Lykos Therapeutics Application for MDMA-AT for PTSD (Lucid News, 9. august)

• The end-of-life patients finding solace in magic mushrooms: "What life after could be like" (The Guardian, 6. august)

• Dying is a Trip (Lucid News, 2. august)

• This Is Literally Your Brain on Drugs (The New York Times, 17. juli)

• Mexico may legalize magic mushroom. Will this traditional medicine lose its meaning? (Los Angeles Times, 25. juni)

• Magic mushrooms helped a Navajo woman deal with trauma. Now she wants to help others (The Guardian, 12. juni)

• Oregon Threatens to Revoke Approval of a Mushroom School That Says It's a Religious Practice (Willamette Weekly, 12 . juni)

• Tram Day Celebrates Female LSD Pioneer Susi Ramstein (Lucid News, 12. juni)

• Oregon's psilocybin industry, a year old, seeks customers (10. juni, Oregon Capital Chronicle)

• I have lifelong anorexia. MDMA and mushrooms showed me remission is possible (The Guardian, 5. juni)

• Can psychedelics treat depression? Maybe, and you might not even have to take a trip (The Guardian, 1. juni)

• Americans have demonized drugs for decades. Now we're doing them every day (The Guardian, 29. mai)

• ‘Shame and betrayal’: sexual abuse within the spiritual healing industry comes to light (The Guardian, 26. mai)

• The VA is quietly fast-tracking MDMA therapy for veterans (The Intercept, 20. mai)

• Psychedelics could treat some of the worst chronic pain in the world (Vox, 15. mai)

• US poised to ease restrictions on marijuana in historic shift, but it'll remain controlled substance (AP News, 1. mai)

• The longest, strangest trip: Some psychedelic drug users are stuck with unwelcome highs (Los Angeles Times, 30. april)

• PTSD crisis looms as troop shortages take toll on Ukrainian soldiers' mental health (Kyiv Independent, 25. april)

• The First Wave of Blotter Acid Inspired Trippy Psychedelic Art (Lucid News, 25. april)

• What a Terror Attack in Isreael Might Reveal About Psychedelics and Trauma (The New York Times, 11. april)

• Six Months After Opening, A Northeast Portland Shroom Center Become the First to Close (Willamette Week, 27. mars)

• The Psychedelic Evangelist (New York Times, 26. mars)

• What psychedelics legislation and decriminalisation looks like around the world (BBC, 24. mars)

• This Man Could Be About Making MDMA Legal for Therapy. Are We Ready For It? (The Guardian, 29. februar)

• Navigating Psychedelic Experiences: Introducing the Psychedelic Preparedness Scale (PPS) (Springer Nature, 13 februar)

• Psychedelic Censorship: Let Mushroom Educators Have Their Say (Rolling Stone, 26. januar)

• Inside the Luxuary World of Illegal Magic Mushroom Chocolate (Bon Appétit, 24. januar)

• European Union funds groundbreaking research into psychedelic therapy ( PAREA, 23. januar)

• Leo Zeff and the non-directive style of being a psychedelic guide (Lucid News, 22. januar)

Forskning
• Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants (Translational Psychiatry, 4. september) (sammendrag)
• Psilocybin desynchronizes the human brain (Nature, 17. juli)

• Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder (Taylor & Francis Online, 23. mai)

• Considering the nocebo effect in the psychedelic discourse (AK Journals, 10. mai)

•Trauma under Psychedelics: MDMA Shows Protective Effects During the Peritraumatic Period (BioRxiv, 28. mars) ("...we investigated the acute experiences and peritraumatic processing of 657 survivors from the high-casualty terror attack at the Supernova music festival in Israel on October 7th, 2023.")

• Development and psychometric validation of a novel scale of measuring "psychedelic preparedness' (Nature, 8 februar)

• Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample (Frontiers, 13 november)

• Cardiovascular safety of psychedelic medicine: current status and future directions (PubmedCentral, 24. oktober)

• People who use psilocybin outside clinical research settings self-report improved mental health and well-being, according to new research from Johns Hopkins University School of Medicine (Frontiers in Psychiatry, 19. september)

• MAPS PBC Publishes Results of Sucessfull Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD (pressemelding MAPS, 14. september) (vitenskapelig artikkel Nature, 14. september)

Viktig informasjon --- Innholdet på disse nettsidene er ment som inspirasjon og kunnskapsdeling – ikke som erstatning for medisinsk rådgivning eller psykisk helsehjelp. Dersom du har spørsmål knyttet til helse, anbefaler vi at du snakker med kvalifisert helsepersonell som kan gi deg støtte og veiledning tilpasset din situasjon.

Psilocybin er i dag klassifisert som et ulovlig narkotisk stoff i Norge. Likevel finnes det mange mennesker som ønsker å utforske stoffet på en trygg og meningsfull måte. Pvit jobber derfor for å fremme en ansvarlig og regulert tilnærming utenfor helsevesenet – der individuelle behov og valg får rom, uten krav om diagnose.

© Prosjekt Pvit 2020 - 2025

Page updated

Google Sites

Report abuse